Zimmer Biomet Q3 sales hit $1.1B, spine sales down 1.9%: 5 key points

Zimmer Biomet reported a net sales increase during the third quarter of 2019.

Advertisement

Five key notes:

1. Net sales jumped 3 percent during the third quarter, hitting nearly $1.9 billion.

2. Quarterly net sales in the Americas were up 2.2 percent to $1.1 billion while the Asia Pacific market experienced nearly 9 percent sales increase to $338 million.

3. Knee sales were up 3.8 percent worldwide to $652 million and hip sales increased 3.5 percent to $460 million. However, spine and craniomaxillofacial sales were down nearly 2 percent to $181 million.

4. For the nine months end, the company reported flat net sales at $5.8 billion.

5. Zimmer Biomet reported $578 million in operating cash flow and $425 million in free cash flow. It also paid down $330 million of debt.

More articles on orthopedic devices:
Stryker bets on extremities, to buy Wright Medical for $5.4B: 5 key notes
Conformis revenue down 40% in Q3, net loss hits $8.7M
7 key notes on orthopedic companies

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Stryker CEO Kevin Lobo’s total compensation was $21.4 million in 2025, according to a recent Securities and Exchange Commission proxy filing.…

  • John DeFord, PhD, is stepping down from Globus Medical’s board of directors, according to a March 23 news release. His…

Advertisement

Comments are closed.